Govt notifies NIAB as central drugs lab for COVID vaccines
Hyderabad: In a move that will speed up the testing and lot release of Covid-19 vaccines, the National Institute of Animal Biotechnology (NIAB), Hyderabad, has been notified as a Central Drugs Laboratory (CDL) by the Union ministry of health & family welfare (MoHFW).The move will bring much respite to Hyderabad-based vaccine makers such as Bharat Biotech, Biological E and...
Login or Register to read the full article
Hyderabad: In a move that will speed up the testing and lot release of Covid-19 vaccines, the National Institute of Animal Biotechnology (NIAB), Hyderabad, has been notified as a Central Drugs Laboratory (CDL) by the Union ministry of health & family welfare (MoHFW).
The move will bring much respite to Hyderabad-based vaccine makers such as Bharat Biotech, Biological E and Indian Immunologicals Ltd, which are engaged in the manufacture Covid-19 vaccines, as all the lots had to be first sent to CDL Kasauli for testing and release.
The notification came after the Central Drugs Standard Control Organisation (CDSCO) furnished a draft notification to MoHFW for notifying NIAB, Hyderabad, as a CDL laboratory.
Apart from NIAB, Hyderabad, the name of National Centre for Cell Sciences (NCCS) at Pune too was recommended.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd